MONOCLONAL ANTIBODY

Views:
 
Category: Education
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

Slide 1:

Seminar on Monoclonal antibody Submitted by : KAUSHIK PATEL

Slide 2:

Introduction Antibodies (1) structure (2)class Differences between monoclonal and polyclonal antibody The types of monoclonal antibody designed Contents

Slide 3:

Monoclonal antibody for cancer treatment Monoclonal antibody development Conventional production of monoclonal antibody Application

Slide 4:

An antibody is a protein used by the immune system to identify and neutralize foreign objects like bacteria and viruses. Each antibody recognizes a specific antigen unique to its target Monoclonal antibodies ( mAb ) are antibodies that are identical because they were produced by one type of immune cell, all clones of a single parent cell. MONOCLON AL ANTIBODY

Slide 5:

ANTIBODIES MONOCLONAL. POLYCLONAL. Derived from different B Lymphocytes cell lines Batch to Batch variation affecting Ab reactivity & titre NOT Powerful tools for clinical diagnostic tests Derived from a single B cell clone mAb offer Reproducible, Predictable & Potentially inexhaustible supply of Ab with specificity Enable the development of secure immunoassay systems.

Slide 6:

Muromonab CD3 ( Orthoclone OKT3): Muromonab CD3 is a murine Mab that reacts with a T3 (CD3) molecule linked to an antigen receptor on the surface membrane of human T-lymphocytes. It blocks both generation and function of the T- cell in response to antigenic challenge and is indicated for treatment of organ transplant rejection. Uusually it is combined withAzathioprine , Cyclosporine and for Corticosteroids to prevent acute rejection of immunosuppressive drugs

Slide 7:

ANTIBODIES STRUCTURE CLASS

Slide 8:

The types of monoclonal antibody designed : Murine source mAbs : rodent mAbs with excellent affinities and specificities, generated using conventional hybridoma technology. Clinical efficacy compromised by HAMA(human anti murine antibody) response, which lead to allergic or immune complex hypersensitivities. Chimeric mAbs : chimers combine the human constant regions with the intact rodent variable regions. Affinity and specificity unchanged. Also cause human antichimeric antibody response (30% murine resource)

Slide 9:

Humanized mAbs : contained only the CDRs of the rodent variable region grafted into human variable region framework

Slide 10:

Monoclonal antibodies for cancer treatment Three mechanisms that could be responsible for the cancer treatment. mAbs act directly when binding to a cancer specific antigens and induce immunological response to cancer cells. Such as inducing cancer cell apoptosis, inhibiting growth, or interfering with a key function. mAbs was modified for delivery of a toxin , radioisotope , cytokine or other active conjugates.

Slide 11:

it is also possible to design bispecific antibodies that can bind with their Fab regions both to target antigen and to a conjugate or effector cell

Slide 12:

MAbs treatment for cancer cells ADEPT- antibody directed enzyme prodrug therapy, ADCC- antibody dependent cell-mediated cytotoxicity , CDC- complement dependent cytotoxicity Mab - monoclonal antibody , scFv - single-chain Fv fragment.

Slide 13:

Humanized antibody in clinical trials or introduse into clinical practice:

Slide 14:

Phage display library : construction of V H and V L gene libaries and expression of them on a filamentous bacterophage . The phage expressing an antigen-bonding domain specific for a particular antigen to screen the mAbs . Transgenic plants : transgenic tobacco plants to produce IgA. Transgenic animals : transgenic mouse to make humanized IgG . M Abs development

Slide 15:

Conventional production of mAbs The hybridoma technology : S pleen cells from immunized mice are fused with the murine myeloma cells. The several process had been developed at large scale. According to the different cell culture methods, it can classified into four fields Robottle cell culture process. Membrane binded cell culture process Microcarrier cell culture process Suspended cell culture process

Slide 16:

PRODUCTION OF MONOCLONAL ANTIBODY HYBRIDOMA TECHNOLOGY

Slide 17:

PRODUCTION OF MONOCLONAL ANTIBODY HYBRIDOMA TECHNOLOGY Department of Pharmaceutics,NIMS Institute of Pharmacy, NIMS University, Jaipur

Slide 18:

Applications of Monoclonal Antibodies Diagnostic Applications Biosensors & Microarrays Therapeutic Applications Transplant rejection- Muronomab-CD3 Cardiovascular disease- Abciximab Cancer - Rituximab Infectious Diseases - Palivizumab Inflammatory disease -Infliximab Clinical Applications Pu rification of drugs, Imaging the target Future Applications Fight against Bioterrorism

authorStream Live Help